|
Prior to joining OVATION Pharmaceuticals in 2003, Dr. Stephen Collins was Global Senior Director of CNS and Pain at Johnson & Johnson, overseeing early-stage development of neurologic and psychiatric agents. At the corporate level, he led the clinical development and implementation of global pharmacovigilance strategy to bring all Johnson & Johnson pharmaceutical companies to a new industry standard. Dr. Collins also worked at Abbott Laboratories Pharmaceutical and Hospital Products Divisions, where he developed drugs for neurologic, psychiatric and pain indications. There, Dr. Collins was also responsible for the clinical program that supported the successful filing of multiple NDA and sNDA submissions. Previously, Dr. Collins founded and directed both the Comprehensive Epilepsy Center and Drug Development Center of the Case Western Reserve University Medical School. | 